LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,093,000 | -63.5% | 376,502 | -56.4% | 0.34% | -65.1% |
| Q4 2018 | $5,728,000 | -37.8% | 862,602 | 0.0% | 0.96% | -33.3% |
| Q3 2018 | $9,204,000 | -11.1% | 862,602 | 0.0% | 1.44% | -16.1% |
| Q2 2018 | $10,351,000 | +41.3% | 862,602 | +0.9% | 1.72% | +30.3% |
| Q1 2018 | $7,324,000 | -11.4% | 854,592 | +2.1% | 1.32% | -5.0% |
| Q4 2017 | $8,271,000 | -8.7% | 837,192 | +13.5% | 1.39% | +0.7% |
| Q3 2017 | $9,063,000 | -11.5% | 737,453 | +18.4% | 1.38% | -7.3% |
| Q2 2017 | $10,243,000 | +115.0% | 622,655 | +87.4% | 1.49% | +96.4% |
| Q1 2017 | $4,765,000 | – | 332,300 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |